The most serious risk associated with ibogaine is cardiac. That's not a fringe concern or a reason to dismiss the treatment — it's the specific, understood, manageable risk that any honest clinic will walk you through before you commit to anything.

Ibogaine has caused deaths. In virtually every documented case, those deaths occurred in settings without proper cardiac screening or physician supervision. The risk is not evenly distributed — it's concentrated in situations where the safety protocol was skipped.

Understanding what proper screening looks like, and what it's screening for, matters both for your safety and for evaluating whether a clinic is taking this seriously.

Why Ibogaine Affects the Heart

Ibogaine prolongs the QT interval — a measurement on an ECG representing the time it takes for the heart's ventricles to electrically reset between beats. When the QT interval is prolonged, the heart becomes vulnerable to a specific arrhythmia called Torsades de Pointes, which can be fatal.

QT prolongation is not unique to ibogaine — many common medications do this, including some antibiotics, antidepressants, and antipsychotics. The issue with ibogaine is the degree of prolongation and the duration of its effect. The drug has a long half-life, so the cardiac effect persists for many hours.

In people who already have a prolonged QT interval or certain cardiac conditions, ibogaine's additional effect can push the heart into dangerous territory. Screening is designed to detect and prevent exactly this.

What Proper Cardiac Screening Includes

ECG (electrocardiogram): The foundation of ibogaine cardiac screening. A 12-lead ECG measures your baseline QT interval and identifies other rhythm abnormalities. This should happen before treatment — not "when you arrive" but before you commit to the program. Some clinics ask you to get an ECG from your own physician and share the results before booking, others won't order the EKG until a day or two before your flood. If you have any history of a heart condition, it's highly advised to screen before you commit to a program.

QTc measurement: The QT interval adjusted for heart rate produces the corrected QT (QTc). Generally, a QTc above 450ms in men or 470ms in women is considered prolonged. Above 500ms is a significant contraindication. Your screening should include this number explicitly — not just "your ECG looks fine."

Bloodwork: Electrolytes — specifically potassium and magnesium — directly affect QT interval. Low levels of either extend the QT independent of any drug. Good screening catches and corrects these before treatment. Blood work should also check kidney and liver function, since ibogaine is metabolized by the liver and impaired function affects drug clearance.

Medical history review: A detailed intake covering cardiovascular history, family history of cardiac events, current medications, and any prior ECG abnormalities. This is as important as the test results — someone with no cardiac history is a different profile from someone whose parent died suddenly.

QTc
The corrected QT interval is the single most important number in ibogaine cardiac screening.
Ask your clinic for your specific value — not just "you passed."

Who Gets Screened Out

Some conditions are absolute contraindications:

  • Prolonged QTc above clinic threshold (typically 450–470ms depending on sex)
  • Known Long QT Syndrome (congenital or acquired)
  • Recent cardiac event — heart attack, arrhythmia requiring intervention
  • Severe liver disease or failure
  • Current use of medications that significantly prolong QT that cannot be safely tapered

Other conditions require case-by-case evaluation: mild to moderate cardiac issues, controlled hypertension, history of arrhythmia that has resolved, or medication regimens that can be modified before treatment.

If you have cardiac concerns, the answer is not to avoid researching ibogaine — it's to get a proper evaluation early. Some people with cardiac histories are cleared after full workup. Some aren't. Knowing before you've committed time and money is better for everyone.

What to Do If You Have Cardiac Concerns

Get your own baseline ECG first. You can get one from your primary care physician or a cardiologist. Ask for the raw QTc measurement, not just a summary. If it's within normal range and you have no cardiac history, you're likely in the screening pool — though the clinic will do their own evaluation independently.

Be transparent with the clinic about your full history. The intake process only protects you if you're honest in it. A clinic that doesn't know about your arrhythmia history can't account for it.

Review your medication list carefully. Many common medications prolong QT. Bring a complete list — including supplements — to your intake conversation. SSRIs in particular require careful consideration: they prolong QT themselves and have interactions with ibogaine's serotonergic mechanisms. Most clinics require an SSRI taper before treatment, which takes weeks to do safely.

During Treatment: What Monitoring Looks Like

At a properly run clinic, cardiac monitoring continues throughout the acute phase. This typically means continuous pulse oximetry and periodic ECG monitoring, with a physician present to respond to any changes. The highest cardiac risk is in the first several hours after administration, when ibogaine levels are peaking.

This is why "physician on-site" is a requirement, not a preference. A nurse who can call a doctor is not the same as a doctor in the room. If something goes wrong with a heart rhythm, the response window is minutes. I was hooked up to an EKG machine with a doctor on site fo